{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-008938","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.389386+00:00","generated_at":"2026-05-16T11:03:18.857477+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"confidence":"high","headline":"Tempest Therapeutics gets Nasdaq notice for missing annual meeting; meeting set for Jan 27, 2026","bullets":["Received Nasdaq deficiency letter on Jan 8, 2026 for failing to hold annual meeting within 12 months of fiscal year end Dec 31, 2024.","Company has 45 calendar days (until Feb 23, 2026) to regain compliance or submit a plan; Nasdaq may grant exception until June 29, 2026.","Annual meeting already scheduled for Jan 27, 2026; upon holding it, compliance will be regained."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-008938","json":"https://secwatch.observer/filing/0001193125-26-008938.json","markdown":"https://secwatch.observer/filing/0001193125-26-008938.md","text":"https://secwatch.observer/filing/0001193125-26-008938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526008938/0001193125-26-008938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526008938/d30095d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:03:18.857477+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}